| 赵欣悦,姜柏生.长春长生疫苗事件中存在的监管问题及建议措施[J].南京医科大学学报(社会科学版),2019,(2):106~109 |
| 长春长生疫苗事件中存在的监管问题及建议措施 |
| Analysis on the supervision issues and suggestions in the case of Changchun Changsheng vaccine |
| 投稿时间：2019-01-24 |
| DOI：10.7655/NYDXBSS20190206 |
| 中文关键词: 疫苗 疫苗监管 建议措施 |
| 英文关键词: vaccine vaccine supervision suggestion |
| 基金项目:国家社会科学基金“医学受试者权利保护研究”（14BFX161） |
|
| 摘要点击次数: 1422 |
| 全文下载次数: 1385 |
| 中文摘要: |
| 根据长春长生疫苗事件暴露出的我国目前在药品安全及监管问题上存在的制度缺陷，结合监管实际，分析我国在疫苗监管方面存在的问题，并提出建议措施。疫苗监管中存在监管体系不健全、监管法制不完善、市场缺乏有效的制约机制等问题。应完善疫苗监管法制，健全疫苗监管体系，发挥市场机制的调节作用，创新疫苗监管方式，以加强我国疫苗安全监管水平。 |
| 英文摘要: |
| According to the system defects in China’s current drug safety and regulatory issues exposed by the Changsheng Biological Vaccine Case, combined with the actual supervision, the problems in vaccine supervision and propose solutions were studied. There are problems such as improper supervision and regulatory legal system, as well as the lack of effective control mechanism in vaccine supervision. The legal system for vaccine supervision and the vaccine supervision system should be improved to for the regulatory role of the market mechanism, the vaccine safety governance model should be innovated to strengthen the level of vaccine safety supervision in China. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |